Robert Roebling

Robert Roebling has a diverse work experience, starting in 1998 as the founder and owner of wxDesigner Software e.K. Robert then worked at Universität Ulm as a Facharzt Neurologie, with a clinical focus on epilepsy, movement disorders, and neurovascular disorders, as well as a scientific focus on epilepsy and neuroimaging. In 2010, they joined Boehringer Ingelheim as a Clinical Program Leader and associate Therapeutic Area Head CNS. Most recently, they have been employed at UCB as a Senior Medical Director since 2017.

Robert Roebling completed their education in the field of medicine. From 1993 to 2000, they studied at The University of Freiburg, where they obtained a degree of Dr. med. Additionally, from 1997 to 1998, they attended Linköping University to further their studies in the same field.